Stonebridge Capital Management’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-8,205
| Closed | -$259K | – | 145 |
|
|
2017
Q1 | $259K | Buy |
+8,205
| New | +$259K | 0.1% | 105 |
|
|
2016
Q4 | – | Sell |
-7,705
| Closed | -$223K | – | 141 |
|
|
2016
Q3 | $223K | Buy |
+7,705
| New | +$223K | 0.1% | 105 |
|
|
2016
Q2 | – | Sell |
-23,470
| Closed | -$581K | – | 149 |
|
|
2016
Q1 | $581K | Buy |
23,470
+8,277
| +54% | +$205K | 0.25% | 68 |
|
|
2015
Q4 | $535K | Sell |
15,193
-21,245
| -58% | -$748K | 0.23% | 79 |
|
|
2015
Q3 | $771K | Buy |
36,438
+225
| +0.6% | +$4.76K | 0.35% | 56 |
|
|
2015
Q2 | $1.01M | Buy |
36,213
+15,083
| +71% | +$419K | 0.41% | 55 |
|
|
2015
Q1 | $646K | Buy |
21,130
+1,755
| +9% | +$53.7K | 0.26% | 78 |
|
|
2014
Q4 | $620K | Sell |
19,375
-7,805
| -29% | -$250K | 0.24% | 85 |
|
|
2014
Q3 | $769K | Sell |
27,180
-2,595
| -9% | -$73.4K | 0.3% | 67 |
|
|
2014
Q2 | $816K | Buy |
29,775
+1,025
| +4% | +$28.1K | 0.31% | 68 |
|
|
2014
Q1 | $757K | Buy |
28,750
+9,410
| +49% | +$248K | 0.31% | 64 |
|
|
2013
Q4 | $566K | Buy |
19,340
+700
| +4% | +$20.5K | 0.23% | 94 |
|
|
2013
Q3 | $570K | Buy |
18,640
+6,275
| +51% | +$192K | 0.26% | 83 |
|
|
2013
Q2 | $392K | Buy |
+12,365
| New | +$392K | 0.18% | 115 |
|